The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 741 Metabolic Health articles
Women on GLP-1 drugs like tirzepatide and semaglutide are reporting surprise pregnancies after significant weight loss. This guide explains the mechanisms, emerging trends, and essential precautions for those on these medications considering family planning.
Jelly Roll transformed from 550 lbs to 265 lbs through disciplined lifestyle changes, avoiding GLP-1 drugs like Ozempic due to vocal health concerns. His story highlights high-protein eating, consistent movement, and overcoming food addiction. Discover actionable strategies backed by science for your own metabolic health journey.
GLP-1 drugs like Ozempic and Mounjaro promise transformative weight loss and blood sugar control, but real users reveal side effects beyond the label. From severe nausea and hair loss to surprising benefits like reduced OCD, these stories highlight the need for informed use. Learn the science, risks, and tips to manage them effectively.
GLP-1 medications like Ozempic and Mounjaro revolutionize weight management by curbing appetite, but pairing them with the right diet is key to lasting results. This guide reveals optimal foods, meal ideas, and strategies to combat nausea while enhancing fat loss. Discover how to eat smart on semaglutide and tirzepatide for metabolic health.
A woman's relapse into an eating disorder after online prescription of GLP-1 drugs highlights growing concerns about telehealth practices. Experts from the Royal College of GPs warn of safety gaps, urging caution with these powerful medications. Discover the science, risks, and best practices for safe use.
Novo Nordisk's oral Wegovy has launched with impressive prescription volumes, offering a pill alternative to injections for weight management. Learn about its efficacy, ideal candidates, dosing, and how it fits into GLP-1 therapy. This guide breaks down the science and practical advice for patients.
GLP-1 drugs such as Ozempic and Wegovy have surged in popularity, with one in eight U.S. adults using them for weight loss or chronic conditions. Beyond shedding pounds, these medications are disrupting economies by curbing appetites and cravings. This guide dives into the clinical mechanisms and real-world impacts on food, fashion, fitness, and beyond.
GLP-1 drugs like Ozempic promise dramatic weight loss, but what happens when you stop? Studies reveal rapid regain—often half or more of lost weight—due to rebound hunger and metabolic shifts. This guide breaks down the mechanisms, evidence, and sustainable strategies.
The MHRA has updated warnings for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, highlighting a rare but serious risk of acute pancreatitis. With 1.6 million UK users in the past year, knowing the symptoms of severe abdominal pain radiating to the back is crucial. This guide breaks down the science, risks, and steps for safe use.
